{
    "2020-09-25": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：特瑞西创减持868.79万股减持计划实施完毕 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "特瑞西创",
                        "减持",
                        "868.79万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：特瑞西创合计减持2.165%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "特瑞西创",
                        "减持",
                        "2.165%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：10月15日前发业绩预告，定增对象未确定",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "业绩预告",
                        "定增",
                        "对象未确定"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业 靶向抗癌新药上市申请获受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "靶向抗癌新药",
                        "上市申请",
                        "获受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}